| 18/05 | VYNE Therapeutics to Present at HC Wainwright & Co. Global Investment Conference |  |
| 17/05 | VYNE THERAPEUTICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form.. | |
| 17/05 | TRANSCRIPT : VYNE Therapeutics Inc. - Special Call | |
| 12/05 | VYNE THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and.. | |
| 12/05 | Earnings Flash (VYNE) VYNE THERAPEUTICS Reports Q1 Loss $-0.14 | |
| 12/05 | Earnings Flash (VYNE) VYNE THERAPEUTICS Reports Q1 Revenue $178,000 | |
| 12/05 | VYNE Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2.. | |
| 12/05 | VYNE Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Up.. | |
| 12/05 | NORTH AMERICAN MORNING BRIEFING : Stocks Seen -3- | |
| 10/05 | VYNE Hosting Key Opinion Leader Event on Novel InhiBET™ BET Inhibitor Platform | |
| 06/05 | VYNE Therapeutics to Present at LifeSci Partners' Immunology & Inflammation Symposium o.. | |
| 08/04 | SECTOR UPDATE : Health Care Stocks Edge Upward Premarket Friday | |
| 07/04 | VYNE Therapeutics Reports 'Positive' Efficacy Results From Phase 1b Portion of Atopic D.. | |
| 07/04 | VYNE THERAPEUTICS : Announces Positive Phase 1b Efficacy Data for FMX114 from Phase 1b/2a .. | |
| 07/04 | VYNE THERAPEUTICS INC. : Changes in Registrant's Certifying Accountant, Other Events, Fina.. | |
| 07/04 | VYNE Therapeutics Reports Positive Efficacy Results From Phase 1B Study of FMX114 to Tr.. | |
| 07/04 | VYNE Therapeutics Announces Positive Phase 1b Efficacy Data for FMX114 from Phase 1b/2a.. | |
| 07/04 | VYNE Therapeutics Inc. Announces Positive Phase 1b Efficacy Data for FMX114 from Phase .. | |
| 30/03 | VYNE Therapeutics Says Preclinical Data Back Further Development of Experimental Joint .. | |
| 30/03 | VYNE THERAPEUTICS : Reports Positive Preclinical Data for Intra-Articular Injection of Pan.. | |
| 30/03 | VYNE THERAPEUTICS INC. : Other Events, Financial Statements and Exhibits (form 8-K) | |
| 30/03 | VYNE Reports Positive Preclinical Data for Intra-Articular Injection of Pan-BET Inhibit.. | |
| 30/03 | VYNE Therapeutics Inc. Reports Positive Preclinical Data for Intra-Articular Injection .. | |
| 21/03 | VYNE THERAPEUTICS INC.(NASDAQGS : VYNE) dropped from S&P Global BMI Index | |
| 17/03 | VYNE THERAPEUTICS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND.. | |
| 17/03 | VYNE THERAPEUTICS : Reports Year-End 2021 Financial Results and Provides Corporate Update .. | |
| 17/03 | Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q4 Revenue $2.29M | |
| 17/03 | VYNE Therapeutics Reports Year-End 2021 Financial Results and Provides Corporate Update | |
| 17/03 | Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q4 Loss $-0.20 | |
| 17/03 | VYNE Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 3.. | |
| 17/03 | VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 20.. | |
| 17/03 | VYNE Therapeutics Inc. Auditor Raises 'Going Concern' Doubt | |
| 15/03 | VYNE THERAPEUTICS INC. : Entry into a Material Definitive Agreement, Change in Directors o.. | |
| 15/03 | VYNE Therapeutics Inc. Appoints Tyler Zeronda as the Chief Financial Officer | |
| 15/03 | VYNE Therapeutics Inc. Names Tyler Zeronda as Treasurer | |
| 08/03 | VYNE THERAPEUTICS INC. : Regulation FD Disclosure (form 8-K) | |
| 07/03 | VYNE Therapeutics Says Drug Candidate Reduces Biomarkers in Preclinical Data in Human S.. | |
| 07/03 | VYNE THERAPEUTICS : Reports Positive Preclinical Data for Lead BET Inhibitor, VYN201, in H.. | |
| 07/03 | VYNE THERAPEUTICS INC. : Other Events, Financial Statements and Exhibits (form 8-K) | |
| 07/03 | VYNE Reports Positive Preclinical Data for Lead BET Inhibitor, VYN201, in Human Skin Mo.. | |
| 07/03 | VYNE Therapeutics Inc. Reports Positive Preclinical Data for Lead Bet Inhibitor, VYN201.. | |
| 04/03 | VYNE THERAPEUTICS INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rul.. | |
| 03/03 | VYNE Therapeutics to Present at 42nd Annual Cowen Healthcare Conference | |
| 03/03 | NORTH AMERICAN MORNING BRIEFING : Oil Prices Top -3- | |
| 19/01 | VYNE Therapeutics Completes Phase 1b Data for FMX114 for Atopic Dermatitis | |
| 19/01 | VYNE THERAPEUTICS : Announces Phase 1b Data for FMX114 from Phase 1b/2a Trial for the Trea.. | |
| 19/01 | VYNE THERAPEUTICS INC. : Other Events, Financial Statements and Exhibits (form 8-K) | |
| 19/01 | VYNE Therapeutics Announces Phase 1b Data for FMX114 from Phase 1b/2a Trial for the Tre.. | |
| 19/01 | VYNE Therapeutics Inc. Announces Phase 1B Data for Fmx114 from Phase 1B/2A Trial for th.. | |
| 14/01 | VYNE THERAPEUTICS : Unaudited Pro Forma Condensed Consolidated Financial Information - For.. | |
| 14/01 | VYNE THERAPEUTICS INC. Change in Directors or Principal Officers, Financial Statements.. | |
| 14/01 | VYNE Therapeutics Inc. Announces Board Changes | |
| 14/01 | Health Care Stocks Drop Premarket Friday | |
| 13/01 | Health Care Stocks Losing More Ground as Biotechs Sputter in Late Trade | |
| 13/01 | SECTOR UPDATE : Health Care | |
| 13/01 | Top Midday Decliners | |
| 13/01 | Wall Street Set for Narrow Gains; US Wholesale Prices Rise Less Than Expected in Decemb.. | |
| 13/01 | Thinking about buying stock in Adagio Therapeutics, Vyne Therapeutics, PetVivo, BTCS In.. | |
| 13/01 | Top Premarket Gainers | |
| 13/01 | Journey Medical Acquires Vyne Therapeutics' Molecule Stabilizing Technology Franchise | |
| 13/01 | VYNE THERAPEUTICS : Divests Topical Minocycline Assets - Form 8-K | |
| 13/01 | VYNE THERAPEUTICS INC. : Entry into a Material Definitive Agreement, Completion of Acquisi.. | |
| 13/01 | VYNE Therapeutics Divests Topical Minocycline Assets | |
| 13/01 | Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and .. | |
| 05/01 | VYNE THERAPEUTICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form.. | |
| 03/01 | VYNE Therapeutics to Participate at the LifeSci Partners 11th Annual Corporate Access E.. | |
| 2021 | VYNE THERAPEUTICS INC.(NASDAQGS : VYNE) dropped from NASDAQ Biotechnology Index | |
| 2021 | Top Premarket Gainers | |
| 2021 | VYNE Therapeutics Shares Surge After HC Wainwright Starts Coverage at Buy | |
| 2021 | Thinking about buying stock in Del Taco Restaurants, Vyne Therapeutics, Lucid Group, AS.. | |
| 2021 | VYNE Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Confer.. | |
| 2021 | VYNE THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and.. | |
| 2021 | TRANSCRIPT : VYNE Therapeutics Inc., Q3 2021 Earnings Call, Nov 10, 2021 | |
| 2021 | VYNE Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months E.. | |
| 2021 | VYNE Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Up.. | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
